Clinical Trial Update: A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating telatinib in combination with chemotherapy for advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Telatinib (telatinib)

Snippet

Sponsor: ACT Biotech, Inc | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED